Continuation of Therapeutic Dose Heparin for Critically Ill Patients with COVID-19: REMAP-CAP Randomized Control Trial

Charlotte A Bradbury^*, Patrick R Lawler, Bryan J McVerry, Ryan Zarychanski

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

4 Citations (Scopus)

21 Downloads (Pure)

Access to Document

Full-text PDF (accepted manuscript)
This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Springer at https://doi.org/10.1007/s00134-023-07095-8 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 206 KBLicence: CC BY

@article{fd6d2dd25b2349e19e61a3f7162564c0,

title = "Continuation of Therapeutic Dose Heparin for Critically Ill Patients with COVID-19: REMAP-CAP Randomized Control Trial",

author = "Bradbury, \{Charlotte A\} and Lawler, \{Patrick R\} and McVerry, \{Bryan J\} and Ryan Zarychanski",

year = "2023",

month = may,

day = "31",

doi = "10.1007/s00134-023-07095-8",

language = "English",

volume = "49",

pages = "873--875",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Continuation of Therapeutic Dose Heparin for Critically Ill Patients with COVID-19

T2 - REMAP-CAP Randomized Control Trial

AU - Bradbury, Charlotte A

AU - Lawler, Patrick R

AU - McVerry, Bryan J

AU - Zarychanski, Ryan

PY - 2023/5/31

Y1 - 2023/5/31

U2 - 10.1007/s00134-023-07095-8

DO - 10.1007/s00134-023-07095-8

M3 - Letter (Academic Journal)

C2 - 37256341

SN - 0342-4642

VL - 49

SP - 873

EP - 875

JO - Intensive Care Medicine

JF - Intensive Care Medicine

ER -